Page 8 of 10

PA20.3 | Plasma Cell Dyscrasias (Multiple Myeloma) — Graded Quiz

Graded 12 questions · Untimed · 2 attempts

Click any question card to reveal the correct answer.

Q1 PA20.3 1 pt

A 68-year-old man presents with a 5-month history of worsening back pain, constitutional symptoms, and progressive renal impairment (creatinine 3.1 mg/dL). Haemoglobin is 8.8 g/dL (normocytic). Serum calcium is 12.4 mg/dL. Total protein is 11.2 g/dL with albumin of 2.9 g/dL. Urine dipstick protein is NEGATIVE. Skeletal X-ray shows multiple punched-out lytic lesions in the skull. Which single investigation will MOST efficiently establish the specific diagnosis?

A Serum PSA (prostate-specific antigen) to exclude metastatic prostate cancer as a cause of lytic lesions
B Serum and urine immunofixation electrophoresis plus bone marrow biopsy
C CT-PET scan to quantify total tumour burden and identify plasmacytomas
D Renal biopsy to characterise the nature of the paraprotein-related nephropathy

Click to reveal answer

Q2 PA20.3 1 pt

A 65-year-old woman with known IgG-κ multiple myeloma complains of increasing bone pain and new-onset leg weakness. MRI spine reveals a T4 vertebral compression fracture with epidural soft tissue extending into the spinal canal. Which pathological mechanism MOST directly explains why myeloma causes purely lytic (not sclerotic) skeletal lesions?

A Myeloma cells secrete PTHrP which activates both osteoclasts and osteoblasts simultaneously, causing net osteolysis due to higher osteoclast sensitivity
B Myeloma cells produce DKK-1 (Dickkopf-1) which inhibits Wnt signalling in osteoblasts, uncoupling osteoclast activation from osteoblast bone formation
C Monoclonal IgG directly dissolves hydroxyapatite crystal in bone matrix through proteolytic enzyme secretion
D IL-6 secreted by myeloma cells activates osteoblasts to deposit amorphous calcium into lytic cavities, paradoxically worsening lysis

Click to reveal answer

Q3 PA20.3 1 pt

A 70-year-old man with IgA-λ multiple myeloma presents with acute confusion, visual blurring, and epistaxis. His M-protein concentration is 6.8 g/dL. Serum viscosity is 6.2 cP (normal <1.8 cP). Fundoscopy shows dilated retinal veins with flame-shaped haemorrhages. Haematocrit is 28%. Urgent plasmapheresis is planned. While the apheresis team prepares, which IMMEDIATE bedside intervention should be performed first to temporarily reduce viscosity?

A Transfuse 2 units of packed red blood cells to correct anaemia and improve oxygen delivery to the retina
B Aggressive IV hydration with normal saline to dilute the circulating paraprotein concentration
C Administer intravenous dexamethasone to rapidly reduce myeloma cell paraprotein secretion
D Perform urgent phlebotomy (venesection) to reduce red cell mass and secondary contribution to viscosity

Click to reveal answer

Q4 PA20.3 1 pt

A 63-year-old man with newly diagnosed multiple myeloma has serum protein electrophoresis showing an M-spike in the gamma region. Immunofixation identifies the paraprotein as IgG-κ with concentration 4.8 g/dL. His haemoglobin is 7.6 g/dL and blood film shows marked rouleaux formation. Which mechanism MOST directly explains the rouleaux formation in his blood film?

A Monoclonal IgG directly cross-links adjacent red cells via Fc-mediated bridging between erythrocyte membranes
B Elevated monoclonal IgG reduces the negative surface charge (zeta potential) on RBCs, promoting face-to-face stacking
C Anaemia of myeloma reduces rouleaux-opposing forces by decreasing the number of RBCs in circulation
D Fibrinogen released by lysed plasma cells aggregates around red cells, causing them to stack

Click to reveal answer

Q5 PA20.3 1 pt

A 67-year-old woman is found to have IgG-κ M-protein 0.9 g/dL on SPEP done for investigation of fatigue. Bone marrow biopsy shows 14% clonal plasma cells. She has no bone pain, no lytic lesions, haemoglobin 12.8 g/dL, calcium 9.2 mg/dL, and creatinine 0.9 mg/dL. Bone survey and MRI spine are normal. Which diagnosis is most appropriate and what is the MOST important management implication?

A MGUS — no treatment required; observe only with annual repeat SPEP and clinical review
B Smouldering multiple myeloma (SMM) — close surveillance required every 3–6 months due to ~10% per year risk of progression to active myeloma
C Symptomatic multiple myeloma — start systemic anti-myeloma therapy (proteasome inhibitor-based regimen) immediately
D Solitary plasmacytoma — treat with local radiotherapy to the bone marrow biopsy site

Click to reveal answer

Q6 PA20.3 1 pt

A 64-year-old man with myeloma presents with progressive breathlessness, orthostatic hypotension, and macroglossia (enlarged, firm tongue). He has bilateral ankle oedema. Serum creatinine is 2.1 mg/dL. Echocardiogram shows concentric left ventricular thickening with a 'granular sparkling' pattern and diastolic dysfunction. 24-hour urine shows 4.2 g of protein. Congo red staining of the rectal biopsy shows apple-green birefringence under polarised light. Which pathological process explains his systemic manifestations?

A Myeloma-related hyperviscosity syndrome causing cardiac wall thickening from RBC sludging in coronary microvessels
B AL (light chain) amyloidosis — monoclonal free light chains misfold into β-pleated sheet fibrils depositing in multiple organs
C Light chain deposition disease (LCDD) — linear non-amyloid light chain deposits in glomerular and vascular basement membranes
D Heavy chain deposition disease from IgG heavy chain deposits in cardiac interstitium and renal mesangium

Click to reveal answer

Q7 PA20.3 1 pt

A 72-year-old woman with IgG myeloma on lenalidomide-dexamethasone therapy develops sudden onset severe lumbar pain after lifting a grocery bag. MRI shows an L3 vertebral compression fracture. Bone densitometry (DEXA) shows T-score −3.8 at the lumbar spine. Which combination of factors MOST directly explains her extreme skeletal fragility?

A Lenalidomide inhibits osteoclasts, paradoxically causing osteomalacia from suppressed bone remodelling
B Myeloma-driven RANKL/DKK-1 osteolysis combined with glucocorticoid (dexamethasone)-induced osteoporosis acting synergistically
C Hypercalcaemia from bone resorption deposits calcium in non-bony tissues, weakening bone cortex
D Amyloid fibril deposition in vertebral trabeculae weakens the bone scaffold

Click to reveal answer

Q8 PA20.3 1 pt

A 60-year-old man with IgA-λ myeloma develops a creatinine rise from 1.0 to 4.2 mg/dL over 6 weeks. His urine protein electrophoresis shows a dense Bence-Jones band (free lambda light chains). Renal biopsy shows large tubular casts that are hard, fractured, and contain both light chains and Tamm-Horsfall protein, with surrounding inflammatory giant cells. Which mechanism MOST directly explains his acute renal failure?

A Hypercalcaemia causes renal vasoconstriction and tubular cell apoptosis, reducing GFR
B Free light chains filtered at the glomerulus co-precipitate with Tamm-Horsfall protein in distal tubules, forming obstructive casts that injure tubular epithelium
C Monoclonal IgA deposits in glomerular mesangium cause immune complex nephritis with haematuria and proteinuria
D NSAIDs taken for bone pain inhibit prostaglandin synthesis, causing afferent arteriolar vasoconstriction and pre-renal AKI

Click to reveal answer

Q9 PA20.3 1 pt

A 58-year-old woman with newly diagnosed IgG-κ multiple myeloma is being counselled on treatment. Her physician explains she will receive a proteasome inhibitor (bortezomib) as part of induction therapy. Which mechanism of action of bortezomib MOST directly explains its efficacy against plasma cell malignancies?

A Bortezomib alkylates DNA of plasma cells, preventing replication of the myeloma clone
B Bortezomib inhibits the 26S proteasome, causing accumulation of misfolded proteins that triggers apoptosis preferentially in antibody-secreting plasma cells
C Bortezomib inhibits RANK-L, reducing osteoclast activation and protecting bone while allowing anti-tumour immune responses
D Bortezomib blocks the IL-6 receptor on plasma cells, preventing the primary myeloma survival signal

Click to reveal answer

Q10 PA20.3 1 pt

A 74-year-old man with a 2-year history of known MGUS (IgG-κ, 1.2 g/dL M-protein, 6% marrow plasma cells) presents with new onset severe back pain. Imaging reveals two new lytic vertebral lesions at T8 and L1. Repeat marrow biopsy shows 32% plasma cells. Haemoglobin is 9.1 g/dL, calcium 11.2 mg/dL, and creatinine 1.8 mg/dL. His serum beta-2 microglobulin is 5.8 mg/L and albumin is 2.8 g/dL. According to the Revised International Staging System (R-ISS), what prognostic stage applies?

A R-ISS Stage I — normal LDH, β2M <3.5 mg/L, albumin ≥3.5 g/dL, and no high-risk cytogenetics
B R-ISS Stage III — β2M 5.8 mg/L (>5.5 threshold) alone qualifies for Stage III regardless of other parameters
C R-ISS Stage II — β2M 3.5–5.5 mg/L with albumin <3.5 g/dL; the low albumin limits this patient to Stage II
D Staging is not applicable as this patient previously had MGUS and has now progressed — a separate prognostic system applies

Click to reveal answer

Q11 PA20.3 1 pt

A 66-year-old woman has a urine sample sent for investigation of suspected multiple myeloma. Standard urine dipstick shows NEGATIVE for protein. However, urine protein electrophoresis shows a large monoclonal spike in the fast gamma region later confirmed as free lambda light chains. Which property of Bence-Jones protein explains the false-negative urine dipstick result?

A Free light chains are too small to be filtered by the glomerulus and therefore are not present in urine in detectable quantities
B Urine dipstick reagent strips use a colorimetric indicator (tetrabromphenol blue) that is specifically sensitive only to albumin, not to free immunoglobulin light chains
C Bence-Jones protein binds to uromodulin (Tamm-Horsfall protein) in the tubule and is not excreted as free light chains in the urine
D The dipstick gives false-negative results due to the alkaline pH of urine in myeloma patients from renal tubular acidosis

Click to reveal answer

Q12 PA20.3 1 pt

A 61-year-old man with IgG myeloma develops a fever of 39.5°C, cough, and hypoxia three weeks after starting a new treatment cycle. His absolute neutrophil count (ANC) is 0.4 × 10⁹/L. Chest X-ray shows bilateral ground-glass infiltrates. Blood cultures are pending. Which organism and risk factor MOST specifically contributes to his infection risk beyond the neutropenia itself?

A Streptococcus pneumoniae — hypogammaglobulinaemia from myeloma impairs opsonising antibody production against encapsulated bacteria
B Staphylococcus aureus — chemotherapy-induced skin barrier disruption allows MRSA bacteraemia
C Aspergillus fumigatus — corticosteroid use impairs macrophage fungicidal activity, and neutropenia further impairs hyphal killing
D CMV — dexamethasone impairs T-cell function and reactivates latent CMV from marrow stromal cells

Click to reveal answer